176 related articles for article (PubMed ID: 27734028)
1. NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline.
Osterburg AR; Nelson RL; Yaniv BZ; Foot R; Donica WR; Nashu MA; Liu H; Wikenheiser-Brokamp KA; Moss J; Gupta N; McCormack FX; Borchers MT
JCI Insight; 2016 Oct; 1(16):e87270. PubMed ID: 27734028
[TBL] [Abstract][Full Text] [Related]
2. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
Fernández-Messina L; Ashiru O; Agüera-González S; Reyburn HT; Valés-Gómez M
J Cell Sci; 2011 Feb; 124(Pt 3):321-7. PubMed ID: 21224393
[TBL] [Abstract][Full Text] [Related]
3. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
4. The regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients.
Mou X; Zhou Y; Jiang P; Zhou T; Jiang Q; Xu C; Liu H; Zheng T; Yuan G; Zhang Y; Chen D; Mao C
Sci Rep; 2014 Aug; 4():6138. PubMed ID: 25138242
[TBL] [Abstract][Full Text] [Related]
5. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
Raneros AB; Minguela A; Rodriguez RM; Colado E; Bernal T; Anguita E; Mogorron AV; Gil AC; Vidal-Castiñeira JR; Márquez-Kisinousky L; Bulnes PD; Marin AM; Garay MCG; Suarez-Alvarez B; Lopez-Larrea C
Oncotarget; 2017 May; 8(19):31959-31976. PubMed ID: 28404876
[TBL] [Abstract][Full Text] [Related]
6. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
[TBL] [Abstract][Full Text] [Related]
7. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.
Brennan K; McSharry BP; Keating S; Petrasca A; O'Reilly VP; Keane J; Doherty DG; Gardiner CM
Hum Immunol; 2016 Oct; 77(10):876-885. PubMed ID: 27349945
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell-mediated shedding of ULBP2.
Wang R; Sun PD
PLoS One; 2014; 9(3):e91133. PubMed ID: 24614922
[TBL] [Abstract][Full Text] [Related]
9. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
10. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
11. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
13. NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.
Sharma N; Trinidad CV; Trembath AP; Markiewicz MA
J Immunol; 2017 Oct; 199(8):2865-2872. PubMed ID: 28893955
[TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study.
Lee GH; An HJ; Kim TH; Kim G; Park KS; Park H; Lee TH; Kwon AY
Yonsei Med J; 2021 Apr; 62(4):288-297. PubMed ID: 33779082
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells.
Jost S; Ahn J; Chen S; Yoder T; Gikundiro KE; Lee E; Gressens SB; Kroll K; Craemer M; Kaynor GC; Lifton M; Tan CS
J Infect Dis; 2024 Jun; 229(6):1836-1844. PubMed ID: 37774496
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor induces immune escape of cervical cancer cells by downregulation of NKG2D.
Song H; Park H; Park G; Kim YS; Lee HK; Jin DH; Kang HS; Cho DH; Hur D
Oncol Rep; 2014 Jul; 32(1):425-30. PubMed ID: 24841552
[TBL] [Abstract][Full Text] [Related]
17. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.
Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R
Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A
Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694
[TBL] [Abstract][Full Text] [Related]
20. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.
Park MJ; Bae JH; Chung JS; Kim SH; Kang CD
Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
